MedTrace Logo

Randomized, Controlled Trial to Test the Efficacy of Interferon Beta in the Treatment of Intermediate Uveitis

NCT00344253 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2012-12-03

No results posted yet for this study

Summary

The purpose of this study is to investigate if interferon beta is superior to the standard treatment with Methotrexate for the treatment of intermediate uveitis and macular edema.

Conditions

Interventions

DRUG

Interferon beta

DRUG

Methotrexate

Sponsors & Collaborators

  • Serono GmbH

    collaborator UNKNOWN

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Matthias D Becker, MD, PhD,FEBO · Interdisciplinary Uveitis Center, University of Heidelberg

  • Friederike Mackensen, MD, FEBO · Interdisciplinary Uveitis Center,University of Heidelberg

  • Regina Max, MD · Interdisciplinary Uveitis Center,University of Heidelberg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-03-31
Primary Completion
2011-03-31
Completion
2012-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00344253 on ClinicalTrials.gov